Caris Life Sciences to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference 2021
News provided by
Share this article
Share this article
IRVING, Texas, Feb. 9, 2021 /PRNewswire/ Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence, focused on fulfilling the promise of precision medicine, announced today that David D. Halbert, Chairman and Chief Executive Officer, Brian J. Brille, Vice Chairman, David Spetzler, MS, MBA, Ph.D., President and Chief Scientific Officer and Thomas Parker, Senior Vice President and Chief Financial Officer will host a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference February 17, 2021, at 4:00 p.m. Eastern time.
Caris Life Sciences Accurately Identifies 21 Cancer Types Using Artificial Intelligence Derived Molecular Signatures
New Data Published in Translational Oncology
News provided by
Share this article
Share this article
IRVING, Texas, Jan. 19, 2021 /PRNewswire/ Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, today announced positive results from a study using MI GPSai™ (Genomic Prevalence Score) an artificial intelligence driven product using DNA sequencing and whole transcriptome data to aid in the diagnosis of cancer.
Caris MI GPSai algorithm trained on genomic data from over 34,000 cases and genomic and transcriptomic data from more than 23,000 cases and was validated on over 19,500 cases. MI GPSai predicted the tumor type in the labeled data set with an accuracy of over 94% on 93% of cases while deliberating amongst 21 possible categories of cancer. When also considering
Integrated Oncology Network Announces Strategic Partnership with Southwest Urology
Cleveland multi-specialty platform pivotal to strategic growth of nationwide networks
News provided by
Share this article
Share this article
NASHVILLE, Tenn. and CLEVELAND, Jan. 7, 2021 /PRNewswire/ Integrated Oncology Network (ION), a nationwide leader in oncology and healthcare management services, and Southwest Urology, a market-leading urology practice, have announced a strategic partnership creating a new multi-specialty platform throughout the greater Cleveland, Ohio market. ION s strategic infrastructure resources and multi-specialty management capabilities coupled with Southwest Urology s service line expertise and in-market relationships align with ION s multi-specialty development strategy. This new venture with Southwest Urology represents a pivotal moment in ION s strategic direction. Our entrance into the urology space with such a highly-respected practice strengthens our capabi